相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study
Maryam Karimi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
Mohammad Mashreghi et al.
NANOSCALE RESEARCH LETTERS (2020)
Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy
Parvin Zamani et al.
LIFE SCIENCES (2020)
Mitochondrial peptides-appropriate options for therapeutic exploitation
Lucia-Doina Popov
CELL AND TISSUE RESEARCH (2019)
Caspases in Cell Death, Inflammation, and Disease
Nina Van Opdenbosch et al.
IMMUNITY (2019)
MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
Parvin Zamani et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways
Jia Song et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Targeting the leptin receptor: To evaluate therapeutic efficacy and anti-tumor effects of Doxil, in vitro and in vivo in mice bearing C26 colon carcinoma tumor
Shahrzad Amiri Darban et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease
P. Hemachandra Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging
Hazel H. Szeto et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Stealth Peptides Target Cellular Powerhouses to Fight Rare and Common Age-Related Diseases
Hazel H. Szeto
PROTEIN AND PEPTIDE LETTERS (2018)
Nanoparticles and targeted drug delivery in cancer therapy
Behdokht Bahrami et al.
IMMUNOLOGY LETTERS (2017)
PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells
Shahrzad Amiri Darban et al.
NANOMEDICINE (2017)
Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model
Seyedeh Alia Moosavian et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors
Javad Akhtari et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity
Manouchehr Teymouri et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response
Lei Jiang et al.
BIOMATERIALS (2015)
Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma
Manouchehr Teymouri et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
Leila Arabi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment
Vikas Jain et al.
CURRENT DRUG DELIVERY (2015)
Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity
H. H. Szeto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer
Jia Zhou et al.
BIOMATERIALS (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models
De-Kuan Chang et al.
PLOS ONE (2013)
Polyethylene Glycol Prevents in Vitro Aggregation of Slightly Negatively-Charged Liposomes Induced by Heparin in the Presence of Bivalent Ions
Hiroko Shibata et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo
Swati Biswas et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells
Xiao-Xing Wang et al.
BIOMATERIALS (2011)
Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1
M. Weyland et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Cardiac side-effects of cancer chemotherapy
Jean-Jacques Monsuez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol
Niravkumar R. Patel et al.
JOURNAL OF LIPOSOME RESEARCH (2010)
Targeting mitochondria for cancer therapy
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Partha Mukhopadhyay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients
Catherine Oakman et al.
CANCER TREATMENT REVIEWS (2009)
Targeting lipophilic cations to mitochondria
Michael P. Murphy
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2008)
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments
Arnaud Beduneau et al.
BIOMATERIALS (2007)
Mitochondriotropics: A review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria
Richard W. Horobin et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Mitochondrial drug delivery and mitochondrial disease therapy - An approach to liposome-based delivery targeted to mitochondria
Yuma Yamada et al.
MITOCHONDRION (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
Cell-permeable, mitochondrial-targeted, peptide antioxidants
Hazel H. Szeto
AAPS JOURNAL (2006)
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury
KS Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Chemotherapy: targeting the mitochondrial cell death pathway
KM Debatin et al.
ONCOGENE (2002)
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
PS Green et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
分享论文
